Home > Insider Trading > Amgen Inc

Amgen Inc (AMGN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
171 - 180
Next >>

15 Best Selling Most Profitable Drugs of All Time

Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market researchers and just ...

Keep Reading →

November 24th, 2017 - News

Top 75 Healthcare Dividend Stocks To Invest In

Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.

Keep Reading →

July 17th, 2017 - Dividend Stocks News

15 Biggest Healthcare Companies in USA

If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies in USA are probably your...

Keep Reading →

July 6th, 2017 - News

Here's How This Week Has Started For The Financial Markets

"U.S. stocks rose on Monday, boosted by technology shares and by defense companies, which rose after the United States and Saudi Arabia signed a multi-billion dollar arms deal.

Keep Reading →

May 22nd, 2017 - Commodities Futures/Forex Gold Market Movers News Tech

Esperion Therapeutics Inc (ESPR): Get It While It's Cheap

At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha.

Keep Reading →

March 20th, 2017 - News Stock Analysis

Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?

Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc.

Keep Reading →

March 17th, 2017 - Market Movers News

Sio Capital Remains Bullish On These Stocks Despite Weak Performance

As a healthcare-focused fund, Michael Castor's Sio Capital registered a terrible 2016, as it lost 18.7% net, compared to the 12% gain registered by the S&P 500 and the 8.3% drop of the MSCI World Healthcare...

Keep Reading →

March 3rd, 2017 - Hedge Fund Investor Letters Hedge Funds News

Why President Trump Wants To Transform The FDA - And What It Could Mean For Biotech Stocks

A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at a level no one has ever...

Keep Reading →

February 23rd, 2017 - News Stock Analysis

Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales

Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen.

Keep Reading →

February 9th, 2017 - News Stock Analysis

FDA Approves Amgen, Inc. (AMGN) Drug For Treating Secondary Hyperparathyroidism

Etelcalcetide, an Amgen, Inc. (NASDAQ:AMGN) drug that is meant to treat secondary hyperparathyroidism has been approved by the U.S. Food and Drug Administration.

Keep Reading →

February 8th, 2017 - News Stock Analysis